These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 2328491

  • 61. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
    Nagahata T, Shibasaki C, Ishii T, Uchida T, Arakawa M, Kusama K, Ekimoto H, Takahashi K.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
    [Abstract] [Full Text] [Related]

  • 62. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
    Catapano CV, Chandler KB, Fernandes DJ.
    Cancer Res; 1991 Apr 01; 51(7):1829-35. PubMed ID: 1706219
    [Abstract] [Full Text] [Related]

  • 63. Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.
    Streifel JA, Howell SB.
    Proc Natl Acad Sci U S A; 1981 Aug 01; 78(8):5132-6. PubMed ID: 6975478
    [Abstract] [Full Text] [Related]

  • 64. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
    Kunugi KA, Vazquez-Padua MA, Miller EM, Kinsella TJ.
    Cancer Res; 1990 Aug 15; 50(16):4962-7. PubMed ID: 2199032
    [Abstract] [Full Text] [Related]

  • 65. Mode of action of 1-beta-D-arabinofuranosylcytosine in human lymphoblasts: differential effects of the drug on chromosomal replication.
    Fridland A.
    Med Pediatr Oncol; 1982 Aug 15; 10 Suppl 1():69-79. PubMed ID: 7162468
    [Abstract] [Full Text] [Related]

  • 66. In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.
    Momparler RL, Goodman J, Karon M.
    Cancer Res; 1975 Oct 15; 35(10):2853-7. PubMed ID: 50882
    [Abstract] [Full Text] [Related]

  • 67. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro.
    Müller WE, Rohde HJ, Beyer R, Maidhof A, Lachmann M, Taschner H, Kahn RK.
    Cancer Res; 1975 Aug 15; 35(8):2160-8. PubMed ID: 1149031
    [Abstract] [Full Text] [Related]

  • 68. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells.
    Bhalla K, Swerdlow P, Grant S.
    Blood; 1991 Dec 01; 78(11):2937-44. PubMed ID: 1954383
    [Abstract] [Full Text] [Related]

  • 69. Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.
    Yang JL, White JC, Capizzi RL.
    Cancer Chemother Pharmacol; 1992 Dec 01; 29(3):236-40. PubMed ID: 1733557
    [Abstract] [Full Text] [Related]

  • 70. Correlation of drug-perturbed marrow cell growth kinetics and intracellular 1-B-D-arabinofuranosylcytosine metabolism with clinical response in adult acute myelogenous leukemia.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Blood; 1987 Apr 01; 69(4):1134-40. PubMed ID: 3470054
    [Abstract] [Full Text] [Related]

  • 71. Effect of cytosine arabinoside triphosphate on the incorporation of 3H-thymidine in mitochondria isolated from HeLa cells.
    Mattoccia LP, Sorrentino R.
    J Cell Physiol; 1979 Oct 01; 101(1):17-23. PubMed ID: 541351
    [Abstract] [Full Text] [Related]

  • 72. A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.
    Zittoun J, Marquet J, David JC, Maniey D, Zittoun R.
    Cancer Chemother Pharmacol; 1989 Oct 01; 24(4):251-5. PubMed ID: 2752506
    [Abstract] [Full Text] [Related]

  • 73. Comparison of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and cytosine arabinoside in the treatment of murine brain tumor.
    Basler GA, Shapiro WR.
    Cancer Treat Rep; 1976 Jul 01; 60(7):875-9. PubMed ID: 64295
    [Abstract] [Full Text] [Related]

  • 74. A novel in vitro model system for studying the action of ara-C.
    Wills P, Hickey R, Ross D, Cuddy D, Malkas L.
    Cancer Chemother Pharmacol; 1996 Jul 01; 38(4):366-72. PubMed ID: 8674160
    [Abstract] [Full Text] [Related]

  • 75. Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples.
    Geoffroy F, Dahut W, Takimoto CH, Grem JL.
    Clin Cancer Res; 1995 Nov 01; 1(11):1345-51. PubMed ID: 9815930
    [Abstract] [Full Text] [Related]

  • 76. Inhibition of DNA polymerase-alpha by ara-CMP in the presence of a regulatory protein extracted from human promyelocytic leukemic cells (HL-60).
    Leclerc JM, Grisé-Miron L, Labonté L.
    Semin Oncol; 1987 Jun 01; 14(2 Suppl 1):226-30. PubMed ID: 3473678
    [Abstract] [Full Text] [Related]

  • 77. Consequences of 2',2'-difluorodeoxycytidine (gemcitabine) on replicative DNA synthesis in intact HL-60 cells.
    Ross DD, Cuddy DP.
    Semin Oncol; 1995 Aug 01; 22(4 Suppl 11):26-34. PubMed ID: 7481841
    [Abstract] [Full Text] [Related]

  • 78. Isolation and purification of large quantities of DNA replication intermediates by pH step alkaline elution.
    Erickson LC, Ross WE, Kohn KW.
    Chromosoma; 1979 Aug 01; 74(2):125-39. PubMed ID: 41688
    [Abstract] [Full Text] [Related]

  • 79. The effects of 5-fluoropyrimidines on nascent DNA synthesis in Chinese hamster ovary cells monitored by pH-step alkaline and neutral elution.
    Jones S, Willmore E, Durkacz BW.
    Carcinogenesis; 1994 Nov 01; 15(11):2435-8. PubMed ID: 7955087
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.